Indefinite Delivery Contract 36E79723D0004

Award Date 4/15/23
Last Date to Order 4/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
The Department of Veterans Affairs National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc. for the supply of atorvastatin calcium tablets over a base year and four one-year option periods. The $72.3M contract provides an uninterrupted source of these pharmaceuticals to support the medication requirements of the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The pre-solicitation notice indicates the agency will issue a full...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor, for the procurement of Prasugrel HCL Tablets in 5mg and 10mg strengths. The contract has a base period of one year and four one-year option periods, with a total ceiling value of $2,445,241.70. This IDC will enable the VA, Department of Defense, Bureau of Prisons, Indian Health...
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned small disadvantaged business, to provide Topiramate tablets over a 1-year base period and four 1-year option periods, for a total potential contract value of $14,134,788.05. The contract will support the VA, Department of Defense, Bureau of Prisons, and Indian Health Service by providing an uninterrupted supply of Topiramate tablets in...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to DR Reddy's Laboratories, Inc. to provide chlorthalidone tablets. The single-award contract has a ceiling value of $7,616,074.14 and a period of performance from November 26, 2022 to November 25, 2025, with a base year and four one-year option periods. The contract aims to procure 25mg and 50mg chlorthalidone tablets in 100-count and 1,000-count bottle sizes to supply the VA,...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the provision of gabapentin tablets. The $23.5 million IDC has a base year and four one-year option periods, with an ultimate completion date of December 31, 2025. The contract aims to establish a reliable source of supply for high-volume gabapentin tablets in various strengths and...
The federal contract IDV SPE2D221D0130 is a single-award indefinite delivery contract awarded to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The $15.9 million contract has a period of performance through June 20, 2026 and was issued by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The contract aims to establish a national supply source for several high-volume pharmaceutical products including gabapentin,...
The federal contract IDV award SPE2D225D0005 is a single-award indefinite delivery contract held by Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business manufacturer and distributor of generic pharmaceuticals. The $10.8 million IDV was awarded by the Defense Logistics Agency Troop Support Medical for a 5-year base period with the potential for additional option years, to provide a national supply source for various prescription drugs including gabapentin, atorvastatin,...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service. The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the supply of Clopidogrel Bisulfate tablets. The $15,979,579.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of April 14, 2026.

The contract aims to provide an uninterrupted supply of Clopidogrel Bisulfate tablets in various bottle configurations to fulfill the estimated annual requirements of over 200,000 units for the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The IDC utilizes firm-fixed pricing and streamlines the procurement of this high-volume pharmaceutical, allowing the government to secure reliable sources while obtaining discounted pricing. The contract will leverage the VA and DoD Pharmaceutical Prime Vendor programs for efficient distribution of the products to government medical facilities for beneficiary care.

Generated 2/19/25, 9:05 AM